Unlocking the Power of Stem-like CD4 T Cells in Cancer Immunotherapy

**Winship Cancer Institute** researchers have discovered a novel immune cell, the stem-like CD4 T cell, crucial for potent anti-tumor responses. Despite often remaining inactive, these cells can be activated to enhance cancer immunotherapies like PD1 blockade, especially in resistant cancers. This breakthrough could lead to new treatment strategies, using mRNA and LNP technology to reprogram these cells.